DeepMirror launches early access programme for its intuitive molecular drug design software

Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Boston ,Massachusetts ,United States ,Lily Ramsey ,Max Jakobs ,Boston Consulting Group ,University Of Cambridge ,Early Access Programme ,Wellcome ,From Deepmirrordec ,Lead Optimisation ,Wellcome Trust ,Software ,Drug Discovery ,Drugs ,